ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,346Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 1749

$2.43M Total Retail Price of All Prescriptions

Rank: 3 out of 1749

493 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

6% of this provider’s 3,521 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$170 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OLANZAPINE 1,038 345 10 1 6
BENZTROPINE MESYLATE 1,002 190 R 2 3
RISPERIDONE 998 232 3 1
CLOZAPINE 938 40 4 11
QUETIAPINE FUMARATE 755 218 5 4
DIVALPROEX SODIUM 640 176 6 15
DIVALPROEX SODIUM ER 586 89 7 13
HALOPERIDOL 415 123 8 21
ABILIFY 396 76 9 5
ZOLPIDEM TARTRATE 358 131 10 9
ZIPRASIDONE HCL 354 36 11 28
SERTRALINE HCL 348 106 12 7
CITALOPRAM HBR 346 96 13 10
LITHIUM CARBONATE 334 46 14 20
SEROQUEL XR 331 102 15 25
SEROQUEL 304 89 16 24
MIRTAZAPINE 302 206 17 16
FLUOXETINE HCL 292 141 18 8
TOPIRAMATE 269 14 19 29
CYMBALTA 251 66 20 12
BUSPIRONE HCL 244 119 21 26
PAROXETINE HCL 237 63 22 19
TRAZODONE HCL 205 33 23 2
FLUVOXAMINE MALEATE 165 52 24 54
RISPERDAL CONSTA 137 36 25 42
TRIHEXYPHENIDYL HCL 136 33 R 26 33
GEODON 130 0 27 55
VIIBRYD 124 31 28 66
GABAPENTIN 118 18 29 27
INVEGA 116 17 30 45
DONEPEZIL HCL 112 65 31 30
ESCITALOPRAM OXALATE 105 27 32 23
FAZACLO 104 0 33 34
OLANZAPINE ODT 96 28 34 40
THIOTHIXENE 96 13 34 74
LAMOTRIGINE 95 0 36 14
BUPROPION HCL SR 88 0 37 22
ZYPREXA 82 26 38 86
PERPHENAZINE 81 0 39 44
VENLAFAXINE HCL ER 76 52 40 17
LATUDA 76 0 40 35
BUPROPION HCL 72 0 42 61
INVEGA SUSTENNA 72 19 42 32
NAMENDA 69 48 44 31
FLUPHENAZINE HCL 69 12 44 36
CHLORPROMAZINE HCL 67 0 46 48
EXELON 65 43 47 51
FANAPT 60 0 48 62
VALPROIC ACID 56 36 49 58
AMITRIPTYLINE HCL 53 0 R 50 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.